- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Synthesis of BACE1 Inhibitor LY3202626 ; volume:16 ; number:05 ; year:2020 ; pages:0495
Synfacts ; 16, Heft 05 (2020), 0495
- DOI
-
10.1055/s-0040-1707929
- URN
-
urn:nbn:de:101:1-2020062507130340082574
- Rights
-
Open Access unbekannt; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Other Objects (12)
Synthesis of a BACE1 Inhibitor
Design and synthesis of BACE1 inhibitors and uPAR-selective ligands for radiotherapy
Fragment-based discovery of BACE1 inhibitors using functional assays
Implications for BACE1 Inhibitor Clinical Trials: Adult Conditional BACE1 Knockout Mice Exhibit Axonal Organization Defects in the Hippocampus
Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
Sorting nexin 12 interacts with BACE1 and regulates BACE1-mediated APP processing
Pharmacological BACE1 inhibitor treatment during early progression of β-amyloid pathology maximizes therapeutic efficacy
The effect of BACE1-AS on β-amyloid generation by regulating BACE1 mRNA expression
Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
Regulation of dynamic BACE1 trafficking in neurons
The global proteomic profiling of the BACE1 knockout mouse brain allows the identification of novel BACE1 candidate substrates in vivo
Synthesis of a BACE1 Inhibitor
Design and synthesis of BACE1 inhibitors and uPAR-selective ligands for radiotherapy
Fragment-based discovery of BACE1 inhibitors using functional assays
Implications for BACE1 Inhibitor Clinical Trials: Adult Conditional BACE1 Knockout Mice Exhibit Axonal Organization Defects in the Hippocampus
Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
Sorting nexin 12 interacts with BACE1 and regulates BACE1-mediated APP processing
Pharmacological BACE1 inhibitor treatment during early progression of β-amyloid pathology maximizes therapeutic efficacy
The effect of BACE1-AS on β-amyloid generation by regulating BACE1 mRNA expression
Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
Regulation of dynamic BACE1 trafficking in neurons
The global proteomic profiling of the BACE1 knockout mouse brain allows the identification of novel BACE1 candidate substrates in vivo
Synthesis of a BACE1 Inhibitor
Design and synthesis of BACE1 inhibitors and uPAR-selective ligands for radiotherapy
Fragment-based discovery of BACE1 inhibitors using functional assays
Implications for BACE1 Inhibitor Clinical Trials: Adult Conditional BACE1 Knockout Mice Exhibit Axonal Organization Defects in the Hippocampus
Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
Sorting nexin 12 interacts with BACE1 and regulates BACE1-mediated APP processing
Pharmacological BACE1 inhibitor treatment during early progression of β-amyloid pathology maximizes therapeutic efficacy
The effect of BACE1-AS on β-amyloid generation by regulating BACE1 mRNA expression
Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
Regulation of dynamic BACE1 trafficking in neurons